Demographic, Cultural Shifts Prime China For OTC Switch Growth
This article was originally published in The Tan Sheet
China’s changing demographics are fueling the potential for OTC switch and “make for a ripe OTC market with vast growth potential,” market researchers say.
You may also be interested in...
Poland, Mexico, South Korea and Indonesia all grew between 5% and 6.5% in 2011, and South Africa, Turkey, Vietnam, the “stans” countries and “fascinatingly” Iran, among others, also are likely areas for future expansion of the OTC and self-care market, consultant Nicholas Hall says.
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.
GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.